Monday, June 2, 2014

Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases.

Higher potency statins (rosuvastatin ≥10 mg, atorvastatin ≥20 mg, and simvastatin ≥40 mg) were found to be associated with a moderate increase in the risk of new onset diabetes compared with lower potency statins. The rate increase in diabetes onset associated with higher vs lower potency statins was 1.15.
Read More